Results 31 to 40 of about 1,262,741 (193)

Relation of Vitamin D Deficiency in Women with Polycystic Ovarian Syndrome in Kirkuk

open access: yesAl-Kitab Journal for Pure Sciences, 2023
Polycystic ovary syndrome is one of the most chronic diseases affecting women. Some studies indicate that the level of vitamin D is related to the development of polycystic ovary syndrome.
Sundus Abdul kaream Mardan   +2 more
doaj   +1 more source

Polycystic Ovary Syndrome: Considerations About Therapeutic Strategies Choices from Fertile Life to Menopause

open access: yes, 2021
Polycystic ovary syndrome (PCOS) is a very frequent endocrine disorder in women since it occurs in as many as 8–10% of women of reproductive age [1, 2]. Due to the multiple heterogeneity of the syndrome [3], there has been no agreement on the criteria on
Martina C.   +8 more
core   +1 more source

Role of insulin-regulated aminopeptidase as potential biomarker in insulin resistant polycystic ovary syndrome patients [PDF]

open access: yesArchives of Endocrinology and Metabolism
Objective: To measure serum insulin-regulated aminopeptidase levels in women diagnosed with polycystic ovary syndrome and to investigate their potential contribution of these levels to the development of insulin resistance, which plays a central role in ...
Osman Köse   +5 more
doaj   +2 more sources

Treatment options for polycystic ovary syndrome [PDF]

open access: yes, 2011
Ahmed Badawy1 Abubaker Elnashar21Department of Obstetrics and Gynecology, Mansoura University, Mansoura, Egypt; 2Department of Obstetrics and Gynecology, Benha University, Benha, EgyptAbstract: Polycystic ovary syndrome (PCOS) is the most common ...
Ahmed Badawy   +2 more
core   +1 more source

Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats [PDF]

open access: yes, 2012
We investigated the effects of different windows of testosterone propionate (TP) treatment during foetal and neonatal life in female rats to determine whether and when excess androgen exposure would cause disruption of adult reproductive function ...
Alan S McNeilly   +17 more
core   +1 more source

Polycystic ovaries and polycystic ovary syndrome

open access: yesGynecological Endocrinology, 1987
In the 50 years or so since the description by Irving F. Stein and Michael L. Leventhal of their finding of unexpectedly enlarged ovaries in a group of women with amenorrhea1, the syndrome we associate with their names has become widely recognized, variously interpreted and a subject of continual fascination for scores of reproductive scientists and ...
openaire   +2 more sources

Leptin, polycystic ovaries and polycystic ovary syndrome [PDF]

open access: yesHuman Reproduction Update, 1999
As soon as leptin was discovered four years ago, its potential as a player in the polycystic ovary syndrome (PCOS) was explored in a primitive way, though little light was shed on the enigma that is PCOS. As a second wave of leptin research is now available, we review how the expanded role of the cytokine in reproduction might yet impact upon our ...
H S, Jacobs, G S, Conway
openaire   +2 more sources

A snapshot of the lives of women with polycystic ovary syndrome: A photovoice investigation. [PDF]

open access: yes, 2014
Polycystic ovary syndrome affects 6  percent of women. Symptoms include hirsutism, acne, and infertility. This research explores the impact of polycystic ovary syndrome on women’s lives using photovoice.
Sheffield, David   +5 more
core   +1 more source

A new model for predicting the occurrence of polycystic ovary syndrome: Based on data of tongue and pulse

open access: yesDigital Health, 2023
Background and objective Polycystic ovary syndrome is one of the most common types of endocrine and metabolic diseases in women of reproductive age that needs to be screened early and assessed non-invasively.
Weiying Wang   +8 more
doaj   +1 more source

Endocrine Disruptors and Polycystic Ovary Syndrome: Phthalates

open access: yes, 2020
Objective: We aimed to investigate a possible role of the endocrine disruptors phthalates, di-2-ethylhexyl phthalate (DEHP) and mono (2-ethylhexyl) phthalate (MEHP), in polycystic ovary syndrome (PCOS) aetiopathogenesis.
Mustafa Kendirci   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy